Dollex Agrotech Limited (DOLLEX) Subscription Status
Live investor category bidding breakdown, shares offered versus bid, and oversubscription multiple.
Category-Wise Subscription Breakdown
| Investor Category | Allocation % | Shares Offered | Shares Bid | Times Subscribed |
|---|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 50% | 5,000,000 | 4,000,000 | 0.80x |
| Non-Institutional Investors (NII / HNI) | 15% | 1,500,000 | 1,350,000 | 0.90x |
| Retail Individual Investors (RII) | 35% | 3,500,000 | 3,850,000 | 1.10x |
| Total Public Issue | 100% | 10,000,000 | 10,000,000 | Disclosed |
Regulatory Bidding Guidelines & SEBI Compliance
Under Securities and Exchange Board of India (SEBI) ICDR regulations, retail investors applying with UPI 2.0 can bid up to a maximum limit of Rs 5,00,000 per application. Bids must be placed at the cutoff price or within the declared price band.
BrokerLens does not publish unofficial or speculative Grey Market Premiums (GMP). Subscription levels indicate past demand during the public issue window and do not guarantee future listing price appreciation or trading gains.
Frequently Asked Questions
What is the total subscription of Dollex Agrotech Limited IPO?
The public issue has recorded a total subscription of approximately Disclosed across all investor categories based on official exchange disclosures.
How is the retail category performing for Dollex Agrotech Limited IPO?
The Retail Individual Investor (RII) portion, which carries a 35% reservation of the net offer under standard book building, has been subscribed approximately 1.10 times.
When does bidding close for Dollex Agrotech Limited IPO?
Official exchange bidding closes at 5:00 PM on 2022-12-20. UPI mandate approvals must typically be confirmed before the mandate cut-off time on the issue closing day.
Where can I verify official bidding figures for DOLLEX?
Official live cumulative bidding data is published directly by the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on their respective public issue portals.